EUR-Lex Access to European Union law

Back to EUR-Lex homepage

This document is an excerpt from the EUR-Lex website

Document 32024R1401

Commission Delegated Regulation (EU) 2024/1401 of 7 March 2024 amending Delegated Regulation (EU) 2022/2104 supplementing Regulation (EU) No 1308/2013 of the European Parliament and of the Council as regards marketing standards for olive oil

C/2024/1390

OJ L, 2024/1401, 21.5.2024, ELI: http://data.europa.eu/eli/reg_del/2024/1401/oj (BG, ES, CS, DA, DE, ET, EL, EN, FR, GA, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

Legal status of the document In force

ELI: http://data.europa.eu/eli/reg_del/2024/1401/oj

European flag

Official Journal
of the European Union

EN

L series


2024/1401

21.5.2024

COMMISSION DELEGATED REGULATION (EU) 2024/1401

of 7 March 2024

amending Delegated Regulation (EU) 2022/2104 supplementing Regulation (EU) No 1308/2013 of the European Parliament and of the Council as regards marketing standards for olive oil

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Regulation (EU) No 1308/2013 of the European Parliament and of the Council of 17 December 2013 establishing a common organisation of the markets in agricultural products and repealing Council Regulations (EEC) No 922/72, (EEC) No 234/79, (EC) No 1037/2001 and (EC) No 1234/2007 (1), and in particular Article 75(2), thereof,

Whereas:

(1)

Commission Delegated Regulation (EU) 2022/2104 (2) lays down rules on the characteristics of the olive oils referred to in Part VIII, points 1 to 6, of Annex VII to Regulation (EU) No 1308/2013.

(2)

The limit values for the characteristics of olive oil laid down in Delegated Regulation (EU) 2022/2104 reflect the trade standard for olive oil and olive-pomace oil of the International Olive Council (IOC) (3) (hereinafter, ‘IOC Trade Standard’).

(3)

At its 116th IOC session which took place on 30 November 2022, the IOC adopted Decision DEC-III.2/116-VI/2022 amending the IOC Trade Standard as regards the limit of Δ-7-stigmastenol for all categories of olive oil. The Union voted in favour of this amendment, in accordance with Council Decision (EU) 2022/2391 (4).

(4)

In order to ensure the implementation at Union level of the most recent international standard on limit values for the parameter Δ-7-stigmastenol established by the IOC, Delegated Regulation (EU) 2022/2104 should be amended accordingly,

HAS ADOPTED THIS REGULATION:

Article 1

Delegated Regulation (EU) 2022/2104 is amended as follows:

(1)

Annex I is amended as follows:

(a)

table B is replaced by the table set out in Annex I to this Regulation;

(b)

its Appendix is deleted;

(2)

Annex III is replaced by the text set out in Annex II to this Regulation.

Article 2

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 7 March 2024.

For the Commission

The President

Ursula VON DER LEYEN


(1)   OJ L 347, 20.12.2013, p. 671, ELI: http://data.europa.eu/eli/reg/2013/1308/oj.

(2)  Commission Delegated Regulation (EU) 2022/2104 of 29 July 2022 supplementing Regulation (EU) No 1308/2013 of the European Parliament and of the Council as regards marketing standards for olive oil, and repealing Commission Regulation (EEC) No 2568/91 and Commission Implementing Regulation (EU) No 29/2012 (OJ L 284, 4.11.2022, p. 1, ELI: http://data.europa.eu/eli/reg_del/2022/2104/oj).

(3)   https://www.internationaloliveoil.org/what-we-do/chemistry-standardisation-unit/standards-and-methods/.

(4)  Council Decision (EU) 2022/2391 of 25 November 2022 on the position to be taken on behalf of the European Union within the Council of Members of the International Olive Council, as regards the trade standard applying to olive oils and olive-pomace oils (OJ L 316, 8.12.2022, p. 86, ELI: http://data.europa.eu/eli/dec/2022/2391/oj).


ANNEX I

‘B.   Purity characteristics

Category

Fatty acid composition  (1)

Total transoleic isomers

(%)

Total trans- linoleic + trans-linolenic isomers

(%)

Stigmasta- dienes

(mg/kg)  (2)

ΔΕCN42

2-glyceryl monopalmitate

(%)

Myristic

(%)

Linolenic

(%)

Arachidic

(%)

Eicosenoic

(%)

Behenic

(%)

Lignoceric

(%)

1.

Extra virgin olive oil

≤ 0,03

≤ 1,00  (3)

≤ 0,60

≤ 0,50

≤ 0,20

≤ 0,20

≤ 0,05

≤ 0,05

≤ 0,05

≤ |0,20 |

≤ 0,9 if total palmitic acid % ≤ 14,00 %

≤ 1,0 if total palmitic acid % > 14,00 %

2.

Virgin olive oil

≤ 0,03

≤ 1,00  (3)

≤ 0,60

≤ 0,50

≤ 0,20

≤ 0,20

≤ 0,05

≤ 0,05

≤ 0,05

≤ |0,20 |

≤ 0,9 if total palmitic acid % ≤ 14,00 %

≤ 1,0 if total palmitic acid % > 14,00 %

3.

Lampante olive oil

≤ 0,03

≤ 1,00

≤ 0,60

≤ 0,50

≤ 0,20

≤ 0,20

≤ 0,10

≤ 0,10

≤ 0,50

≤ |0,30 |

≤ 0,9 if total palmitic acid % ≤ 14,00 %

≤ 1,1 if total palmitic acid % > 14,00 %

4.

Refined olive oil

≤ 0,03

≤ 1,00

≤ 0,60

≤ 0,50

≤ 0,20

≤ 0,20

≤ 0,20

≤ 0,30

≤ |0,30 |

≤ 0,9 if total palmitic acid % ≤ 14,00 %

≤ 1,1 if total palmitic acid% > 14,00 %

5.

Olive oil composed of refined olive oil and virgin olive oils

≤ 0,03

≤ 1,00

≤ 0,60

≤ 0,50

≤ 0,20

≤ 0,20

≤ 0,20

≤ 0,30

≤ |0,30 |

≤ 0,9 if total palmitic acid% ≤ 14,00 %

≤ 1,0 if total palmitic acid% > 14,00 %

6.

Crude olive-pomace oil

≤ 0,03

≤ 1,00

≤ 0,60

≤ 0,50

≤ 0,30

≤ 0,20

≤ 0,20

≤ 0,10

≤ |0,60 |

≤ 1,4

7.

Refined olive-pomace oil

≤ 0,03

≤ 1,00

≤ 0,60

≤ 0,50

≤ 0,30

≤ 0,20

≤ 0,40

≤ 0,35

≤ |0,50 |

≤ 1,4

8.

Olive-pomace oil

≤ 0,03

≤ 1,00

≤ 0,60

≤ 0,50

≤ 0,30

≤ 0,20

≤ 0,40

≤ 0,35

≤ |0,50 |

≤ 1,2

Table B continued

Category

Sterols composition

Total sterols

(mg/kg)

Erythrodiol and uvaol (**) (%)

Waxes (**) (mg/kg)

Chole-sterol (%)

Brassica-sterol (%)

Campe-sterol(%)

Stigmasterol (%)

Apparent β–sito-sterol  (4) (%)

Δ-7-stigma-stenol (%)

1.

Extra virgin olive oil

≤ 0,5

≤ 0,1

≤ 4,0  (5)

< Camp.

≥ 93,0

≤ 0,5  (6)

≥ 1 000

≤ 4,5

C42 + C44 + C46 ≤ 150

2.

Virgin olive oil

≤ 0,5

≤ 0,1

≤ 4,0  (5)

< Camp.

≥ 93,0

≤ 0,5  (6)

≥ 1 000

≤ 4,5

C42 + C44 + C46 ≤ 150

3.

Lampante olive oil

≤ 0,5

≤ 0,1

≤ 4,0

≥ 93,0

≤ 0,5  (7)

≥ 1 000

≤ 4,5  (8)

C40 + C42 + C44 + C46 ≤ 300 (8)

4.

Refined olive oil

≤ 0,5

≤ 0,1

≤ 4,0

< Camp.

≥ 93,0

≤ 0,5  (9)

≥ 1 000

≤ 4,5  (10)

C40 + C42 + C44 + C46 ≤ 350

5.

Olive oil composed of refined olive oil and virgin olive oils

≤ 0,5

≤ 0,1

≤ 4,0

< Camp.

≥ 93,0

≤ 0,5  (9)

≥ 1 000

≤ 4,5

C40 + C42 + C44 + C46 ≤ 350

6.

Crude olive-pomace oil

≤ 0,5

≤ 0,2

≤ 4,0

≥ 93,0

≤ 0,5  (11)

≥ 2 500

> 4,5  (12)

C40 + C42 + C44 + C46 > 350 (12)

7.

Refined olive-pomace oil

≤ 0,5

≤ 0,2

≤ 4,0

< Camp.

≥ 93,0

≤ 0,5  (11)

≥ 1 800

> 4,5

C40 + C42 + C44 + C46 > 350

8.

Olive-pomace oil

≤ 0,5

≤ 0,2

≤ 4,0

< Camp.

≥ 93,0

≤ 0,5  (11)

≥ 1 600

> 4,5

C40 + C42 + C44 + C46 > 350

Notes:

(a)

The results of the analyses must be expressed to the same number of decimal places as used for each characteristic. The last digit must be increased by one unit if the following digit is greater than 4.

(b)

If just a single characteristic does not match the values stated, the category of an oil shall be changed or the oil shall be declared non-compliant for the purposes of this Regulation.

(c)

For lampante olive oil, both quality characteristics marked with an asterisk (*) may differ simultaneously from the limits established for that category.

(d)

If a characteristic is marked with two asterisks (**), this means that for crude olive-pomace oil, it is possible for both the relevant limits to be different from the stated values at the same time. For olive-pomace oil and refined olive-pomace oil, one of the relevant limits may be different from the stated values.’


(1)  Other fatty acids content (%): palmitic: 7,00-20,00; palmitoleic: 0,30-3,50; heptadecanoic: ≤ 0,40; heptadecenoic ≤ 0,60; stearic: 0,50-5,00; oleic: 55,00-85,00; linoleic: 2,50-21,00.

(2)  Total isomers which could (or could not) be separated by capillary column.

(3)  When the linolenic acid is more than 1,00 but less than or equal 1,40, the ratio apparent β-sitosterol/campesterol has to be greater than or equal to 24.

(4)  Apparent β-sitosterol: Δ-5,23-stigmastadienol+clerosterol+ β-sitosterol+sitostanol+ Δ-5-avenasterol+ Δ-5,24-stigmastadienol.

(5)  An extra virgin or virgin olive oil that exhibits 4,0 < campesterol % ≤ 4,5 is authentic provided that stigmasterol ≤ 1,4 %, Δ-7-stigmastenol ≤ 0,3 % and all other parameters lie within the limits fixed in this Regulation.

(6)  An extra virgin or virgin olive oil that exhibits 0,5 < Δ-7-stigmastenol % ≤ 0,8 is authentic provided that apparent β-sitosterol/campesterol ≥ 28, ΔECN42 ≤|0,10| and all other parameters lie within the limits fixed in this Regulation.

(7)  A lampante olive oil that exhibits 0,5 < Δ-7-stigmastenol % ≤ 0,8 is authentic provided that apparent β-sitosterol/campesterol ≥ 28, ΔΕCN42 ≤ |0,15|, stigmastadienes ≤ 0,30 mg/kg and all other parameters lie within the limits fixed in this Regulation.

(8)  Oils with a wax content of between 300 mg/kg and 350 mg/kg are considered to be lampante olive oil if the total aliphatic alcohol content is less than or equal to 350 mg/kg or if the erythrodiol and uvaol content is less than or equal to 3,5 %.

(9)  A refined olive oil or olive oil composed of refined olive oil and virgin olive oils that exhibits 0,5 < Δ-7-stigmastenol % ≤ 0,8 is authentic provided that apparent β-sitosterol/campesterol ≥ 28, ΔΕCN42 ≤ |0,15| and all other parameters lie within the limits fixed in this Regulation.

(10)  Oils with an erythrodiol + uvaol content of between 4,5 and 6 % must have an erythrodiol content of less than or equal to 75 mg/kg.

(11)  A crude olive-pomace oil or refined olive-pomace oil or olive-pomace oil that exhibits 0,5 < Δ-7-stigmastenol % ≤ 0,8 is authentic provided that stigmasterol ≤ 1,4 %, ΔECN42 ≤ |0,40| and all other parameters lie within the limits fixed in this Regulation.

(12)  Oils with a wax content of between 300 mg/kg and 350 mg/kg are considered to be crude olive-pomace oil if the total aliphatic alcohol content is above 350 mg/kg and if the erythrodiol and uvaol content is greater than 3,5 %.


ANNEX II

‘ANNEX III

CORRELATION TABLE

Implementing Regulation (EU) No 29/2012

Regulation (EEC) No 2568/91

This Regulation

Implementing Regulation (EU) 2022/2105

Article 1, point (a)

 

 

Article 1

 

Article 2(2)

Article 1(1)

 

Article 1, point (b), and Article 1(2)

 

Article 1(2)

 

Article 1, point (b)

 

Article 2, first paragraph

 

Article 4(1)

 

Article 2, second paragraph

 

Article 4(2)

 

Article 3, first paragraph

 

Article 6(1)

 

Article 3, second paragraph, points (a) to (d)

 

Article 6(2), points (a) to (d)

 

Article 4(1), first subparagraph

 

Article 8(1)

 

Article 4(1), second subparagraph

 

Article 8(2)

 

Article 4(1), third subparagraph

 

 

Article 4(2)

 

Article 8(3)

 

Article 4(3)

 

Article 8(4)

 

Article 4(4)

 

Article 8(5)

 

Article 4(5), first subparagraph

 

Article 8(6)

 

Article 4(5), second subparagraph

 

Article 8(7)

 

Article 4a

 

Article 7

 

Article 4b

 

Article 5

 

Article 5, first paragraph, points (a) to (d)

 

Article 10, points (a) to (d)

 

Article 5, first paragraph, point (e)

 

Article 11(1) and (2)

 

Article 5, second paragraph

 

 

Article 5a, first paragraph

 

Article 11(3)

 

Article 5a, second paragraph

 

Article 11(4)

 

Article 5a, third paragraph

 

Article 11(5)

 

Article 6(1), first subparagraph

 

Article 12(1)

 

Article 6(1), second subparagraph

 

Article 12(2)

 

Article 6(1), third subparagraph

 

Article 3(3)

 

Article 6(2), first subparagraph

 

Article 12(3)

 

Article 6(2), second subparagraph

 

Article 12(4)

 

Article 6(3)

 

Article 12(5)

 

Article 12(6)

 

Article 6(4)

 

 

Article 7

 

 

Article 5(2)

Article 8(1)

 

 

Article 2(3)

Article 8(2)

 

 

Article 4(3)

Article 8(3)

 

 

Article 4(2)

Article 8(4)

 

 

Article 4(3)

Article 8a

 

 

Article 2(1) and Article 4(1)

Article 9(1), first subparagraph

 

 

Article 13(1)

Article 9(1), second subparagraph

 

 

Article 13(2)

Article 9(1), third subparagraph

 

 

Article 9(1), fourth subparagraph

 

 

Article 9(1), fifth subparagraph

 

 

Article 9(2),first subparagraph

 

 

Article 6(1)

Article 9(2), second subparagraph, points (a), (b) and (c)

 

 

Article 6(2), points (a), (b) and (c)

Article 9(2), third subparagraph

 

Article 9

 

 

 

Article 6(3)

Article 10, first paragraph, introductory sentence

 

 

Article 14

Article 10, first paragraph, points (a) to (d), and second paragraph

 

 

Article 10a

 

 

Article 14

Annex I

 

 

Annex II

 

 

 

Article 1(1)

Article 2(1), points (a) and (b)

 

 

Article 1(2)

Article 2(1), point (c)

 

 

Article 1(3)

Article 2(1), point (d)

 

 

Article 1(4)

Article 2(1), point (e)

 

 

Article 1(5)

Article 2(1), point (f)

 

 

Article 1(6)

Article 2(1), point (g)

 

 

Article 1(7)

Article 2(1), point (h)

 

Article 2(2)

 

Article 3(1) and (2)

 

 

Article 2(1)

 

Article 7

 

Article 2(1), point (a)

 

Annex I, point 1

 

Article 2(1), point (b)

 

Annex I, point 2

 

Article 2(1), point (c)

 

 

Article 2(1), point (d)

 

 

Article 2(1), point (e)

 

Annex I, point 3

 

Article 2(1), point (f)

 

Annex I, point 4

 

Article 2(1), point (g)

 

Annex I, point 6

 

Article 2(1), point (h)

 

 

Article 2(1), point (i)

 

Annex I, point 5

 

Article 2(1), point (j)

 

Annex I, point 9

 

Article 2(1), point (k)

 

Annex I, point 10

 

Article 2(1), point (l)

 

Annex I, point 8

 

Article 2(1), point (m)

 

Annex I, point 7

 

Article 2(2), first subparagraph and part of point 9.4 of Annex XII

 

Article 10(1)

 

Article 2(2), second subparagraph

 

Article 11(1)

 

Article 2(2), third subparagraph

 

Article 11(2)

 

 

Article 11(3)

 

part of point 9.4 of Annex XII

 

Article 11(4)

 

Article 2(3), first subparagraph

 

Article 3(1)

 

Article 2(3), second subparagraph

 

Article 3(2)

 

Article 2(4), first subparagraph

 

Article 9(2)

 

Article 2(4), second subparagraph

 

Article 9(3)

 

Article 2(4), third subparagraph

 

Article 9(4)

 

Article 2(5)

 

Article 9(5)

 

Article 2a(1)

 

Article 3(1)

 

Article 2a(2)

 

Article 3(3)

 

Article 2a(3)

 

Article 3(4)

 

Article 2a(4), first subparagraph

 

Article 3(5)

 

Article 2a(4), second subparagraph

 

Article 3(2)

 

Article 2a(5)

 

Article 9(1)

 

Article 3, first paragraph

 

Article 13(1)

 

Article 3, second paragraph

 

Article 3(6)

 

Article 4(1), first subparagraph

 

Article 10(1)

 

Article 4(1), second subparagraph

 

Article 10(2)

 

Article 4(1), third subparagraph

 

Article 10(3)

 

Article 4(2)

 

Article 10(4)

 

Article 4(3)

 

-

 

Article 6(1)

 

Article 12(1)

 

Article 6(2)

 

Article 12(2)

 

Article 7

 

 

Article 7a, first subparagraph

 

Article 5(1)

 

Article 7a, second paragraph

 

Article 2(2)

 

Article 8(1)

 

 

Article 8(2)

 

Article 14

 

Annex I

Annex I

 

 

Annex XII, point 3.3

Annex II

 

 

Annex Ia, except for point 2.1

 

Annex II

 

Annex Ia, point 2.1

 

Article 9(6)

 

Annex Ib

 

Annex III

 

Annex III

 

 

Annex IV

 

 

Annex VII

 

 

Annex IX

 

 

Annex X

 

 

Annex XI

 

 

Annex XII, except for point 3.3 and part of point 9.4

 

 

Annex XV

 

Annex IV

 

Annex XVI

 

 

Annex XVII

 

 

Annex XVIII

 

 

Annex XIX

 

 

Annex XX

 

 

Annex XXI

 

Annex V


ELI: http://data.europa.eu/eli/reg_del/2024/1401/oj

ISSN 1977-0677 (electronic edition)


Top